Health economics

Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?
Linda Mary Davies, Emily Anne Fargher, Karen Tricker, Peter Dawes, David L Scott, Deborah Symmons

Annals of the Rheumatic Diseases May 2007, 66 (5) 658-663; DOI: 10.1136/ard.2006.061234
A1.54 Development of a novel bispecific therapeutic for rheumatoid arthritis
Mathieu Ferrari, Shimobi Onuoha, Daniele Sblattero, Costantino Pitzalis

Annals of the Rheumatic Diseases Mar 2014, 73 (Suppl 1) A23; DOI: 10.1136/annrheumdis-2013-205124.53
Intravenous gammaglobulins in refractory polymyositis: lower dose for maintenance treatment is effective
S Genevay, A Saudan-Kister, P-A Guerne

Annals of the Rheumatic Diseases Jun 2001, 60 (6) 635-636; DOI: 10.1136/ard.60.6.635
Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Jonas K Eriksson, Kari Johansson, Johan Askling, Martin Neovius

Annals of the Rheumatic Diseases Apr 2015, 74 (4) 648-654; DOI: 10.1136/annrheumdis-2013-204080
The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial
Mwidimi Ndosi, Martyn Lewis, Claire Hale, Helen Quinn, Sarah Ryan, Paul Emery, Howard Bird, Jackie Hill

Annals of the Rheumatic Diseases Nov 2014, 73 (11) 1975-1982; DOI: 10.1136/annrheumdis-2013-203403
New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
David L Scott, Andrew Cope

Annals of the Rheumatic Diseases Jun 2009, 68 (6) 767-769; DOI: 10.1136/ard.2008.105940
Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial
G Kobelt, P Lindgren, A Singh, L Klareskog

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1174-1179; DOI: 10.1136/ard.2004.032789
Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis
S M M Verstappen, J W G Jacobs, D M van der Heijde, Sj van der Linden, C M Verhoef, J W J Bijlsma, A Boonen

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 727-731; DOI: 10.1136/ard.2006.061283
Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment
S Gaitonde, E Pathan, A Sule, G Mittal, V R Joshi

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 251-253; DOI: 10.1136/ard.61.3.251
Antibiotic prophylaxis for haematogenous bacterial arthritis in patients with joint disease: a cost effectiveness analysis
P Krijnen, C J E Kaandorp, E W Steyerberg, D van Schaardenburg, H J Bernelot Moens, J D F Habbema

Annals of the Rheumatic Diseases Apr 2001, 60 (4) 359-366; DOI: 10.1136/ard.60.4.359

Main menu

Health economics

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Health economics

Pages